Ignite Creation Date:
2025-12-17 @ 9:11 PM
Ignite Modification Date:
2025-12-18 @ 2:11 AM
Study NCT ID:
NCT00720980
Status:
None
Last Update Posted:
2024-04-30 00:00:00
First Post:
2008-07-21 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
Sponsor:
None
Organization:
Study Overview
Official Title:
Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
Status:
None
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We will document the regimen treatment each patient has had and then review the following from the patient's chart to target our specific aims as outlined above.
1. What previous treatment options have been or/are currently being used?
2. How long did the patient take the treatment for?
3. Was the patient able to discontinue or become less dependent on prior treatment?
4. Was the disease process slowed by the treatment?;
5. Were there any side effects that the patient experienced with treatment?
1. What previous treatment options have been or/are currently being used?
2. How long did the patient take the treatment for?
3. Was the patient able to discontinue or become less dependent on prior treatment?
4. Was the disease process slowed by the treatment?;
5. Were there any side effects that the patient experienced with treatment?
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: